To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Innovation

2019 Perceptions and Insights Study: Part 2

CISCRP Feature Image 2

Editor’s note: In this second installment of our two-part infographic series based on the 2019 Perceptions & Insights Study from the Center for Information and Study on Clinical Research Participation (CISCRP), we focus on the use of technology in clinical research and how it may pave the way to decentralized clinical trials.

“You never change things by fighting the existing reality. To change something, build a new model which makes the existing model obsolete.” Buckminster Fuller – theorist, author, designer, inventor, and futurist.

The traditional model where brick and mortar sites require research participants to travel to the research sites for each visit is being challenged by the possibility of a new model called decentralized clinical research or decentralized clinical trials. Instead of bringing the participant to the research site, we are seeking to deliver the research care to the participant’s home through approaches such as mobile nursing, direct-to-patient supply shipment, and technology.

In order to enable the at-home model, we first need to enable the technology that will allow for decentralized research to be effective. As you can see from the first chart below, an across the board increase from 2017 to 2019 has occurred in usage of smartphone apps, text messaging, wearable devices, and concierge services in clinical research. Additionally, only 27% of the people surveyed said they did not use any of the technology options provided in the survey list (down from 40% in 2017).

Participation in clinical research can be quite burdensome to participants, given the demands required in research protocols. The CISCRP 2019 Perceptions & Insights Study identified a slight decrease in those that found participation to be not at all disruptive, from 51% in 2017 to 44% in 2019. The top reasons cited for the disruption included travel to and from the clinic site (55% reported one-way travel time of >30 min), length of visits, diagnostic tests, and health questionnaires.

As you can see from the final infographic below, there is an across-the-board desire to allow for alternatives to traveling to a clinic site for all visits. Most people are interested in allowing for mobile nurses to come into their home to conduct the visit (79%), as well as a blended model where some visits are in the home and some are at the clinic site (73%). Additionally, 75% of participants would like to collect data on their own at home.

The concept of decentralized clinical research, when possible based on the requirements of the trial protocol, can help reduce the burden to participants by saving them time and energy and by allowing more flexibility. It is clear by the survey results that participants are desiring new options to participate in clinical research.

For the full CISCRP 2019 Perceptions and Insights Study, click on this link: https://e.lilly/340iffj

CISCRP Infographic Part 2

Tags: Education, Infographic,

Recent Articles

RecommendationsforDecentralizedClinicalTrialCapabilitiesintheWakeofCOVID-19 FeatureImage 22July2021-01

Recommendations for Decentralized Clinical Trial Capabilities in the Wake of COVID-19

Kevin Hudziak Photo
Kevin Hudziak
September 15th, 20214 minute read

Tips to implement an effective and successful decentralized clinical trial for multiple touch points.

CommittedToCancerResearch FI 8Sept2021-01

Committed to Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 24th, 20211 minute read

Lilly has a strong legacy in cancer research. Our dedicated oncology team work together to create medicines that make life better for people around the world.

ProudPartners FeatureImage 17Sept2021-01

Proud Partners in Breast Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 22nd, 20213 minute read

Lilly is proud to foster true partnerships with external stakeholders. By working together to raise awareness of breast cancer research, we can make life better for people around the world.

TheCOVID-19PandemicChangedHowSitesConductClinicalTrialsForever FeatureImage 22July2021-01

The COVID-19 Pandemic Changed How Sites Conduct Clinical Trials Forever

Kevin Hudziak Photo
Kevin Hudziak
July 29th, 20213 minute read

To better understand how various countries adapted to execute clinical trials during a pandemic, we conducted a series of virtual feedback sessions with clinicians from all over the world.

ThePathFromHCPtoResearcher FeatureImage 24Feb2021-01

The Path from HCP to Researcher: A Word of Advice

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
April 21st, 20215 minute read

If you’re a physician interested in getting involved in clinical research, you must understand that it can be a big career shift. Luckily, Kamnesh Pradhan has valuable advice to share.